Applied Clinical Trials Direct


Applied Clinical Trials Direct Having trouble viewing this e-mail? Click here.	You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe or edit your member profile: Click here.

News Roundup: InspireMD Celebrates Successful ICI 2010 Meeting

Feature Interview: Kenneth A. Getz - Clinical Trial Insights

Blog Posts: Interview With The European Medicine Agency’s Thomas Lönngren

Marketplace: PYRAMID Laboratories Inc

	InspireMD Celebrates Successful ICI 2010 Meeting; Long-Term Data Validates MGuard as Potentially Important Tool
	Sanofi-aventis and Oxford University Collaborate to Conduct Oncology Research in India
	Teysuno? (S-1) Receives CHMP Positive Opinion for Approval as First-Line Therapy for Advanced Gastric Cancer
	Foundation Venture Capital Group Invests in Start-Up Company Working to Improve Mobility for People with Chronic Spinal Cord Injuries
	An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety

Kenneth A. Getz
Clinical Trial Insights

	Interview With The European Medicine Agency’s Thomas Lönngren Kayda Norman Assistant Editor Interview With The European Medicine Agency’s Thomas Lönngren
	Patients, Subjects, Participants, Other Lisa Henderson Editor in Chief Interview With The European Medicine Agency’s Thomas Lönngren
	Interview With The European Medicine Agency’s Thomas Lönngren Kayda Norman Assistant Editor Interview With The European Medicine Agency’s Thomas Lönngren
	Patients, Subjects, Participants, Other Lisa Henderson Editor in Chief Interview With The European Medicine Agency’s Thomas Lönngren
	Patients, Subjects, Participants, Other Lisa Henderson Editor in Chief Interview With The European Medicine Agency’s Thomas Lönngren

Sponsored
PYRAMID Laboratories Inc
PYRAMID is a contract Aseptic Manufacturing and Analytical Services for Sterile Injectable Drugs. PYRAMID provides expertise in formulation and process development, and aseptic filling for vials and syringes, as well as lyophilization applications for Clinical and Commercial products.

Lisa Henderson
Editor in Chief lhenderson@advanstar.com

	InspireMD Celebrates Successful ICI 2010 Meeting; Long-Term Data Validates MGuard as Potentially Important Tool
	Sanofi-aventis and Oxford University Collaborate to Conduct Oncology Research in India
	Teysuno? (S-1) Receives CHMP Positive Opinion for Approval as First-Line Therapy for Advanced Gastric Cancer
	Foundation Venture Capital Group Invests in Start-Up Company Working to Improve Mobility for People with Chronic Spinal Cord Injuries
	An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety

Kenneth A. Getz · Kayda Norman · Lisa Henderson · Kenneth A. Getz · Lisa Henderson · Kayda Norman · Kenneth A. Getz · Kenneth A. Getz ·Kenneth A. Getz · Kenneth A. Getz · Kenneth A. Getz · Kayda Norman · Lisa Henderson · Kenneth A. Getz · Lisa Henderson · Kayda Norman · Kenneth A. Getz · Kenneth A. Getz ·Kenneth A. Getz · Kenneth A. Getz

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe or edit your member profile: click here.To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.